The chemotherapy is designed to make space in the bone marrow for the gene -
corrected hematopoietic stem cells to settle in and start working.
Not exact matches
For now, Porteus and his team found that their
corrected human
hematopoietic stem cells seemed to behave like normal, healthy human
hematopoietic stem cells.
Basically what was happening when you use a
hematopoietic stem cell to
correct an inherited metabolic disease is that through engraftment of that cell you are allowing that cell to become the replacement source for the missing enzyme or other factor - almost like a cellular form of gene therapy or, as I call it, «poor man's gene therapy».